ICAM1, a cell surface glycoprotein present on leukocytes and endothelial cells, has been implicated in recent research, which suggests that its activation enhances the stemness of HNSCC cells, potentially contributing to docetaxel resistance (26). The gene discussed is ICAM1; the disease is head and neck squamous cell carcinoma.